The Use of Ceftaroline as Surgical Prophylaxis in Surgery With Risk of MRSA Infection
Status unconfirmed · Phase 4
Conditions studied: Surgical Site Infection
In brief
The study is a randomized double-blinded study comparing ceftaroline to standard of care therapy with cefazolin and vancomycin as surgical prophylaxis for high risk orthopedic and cardiac surgeries. Study participants will be enrolled from those undergoing cardiothoracic surgery involving sternotomy and those undergoing prosthetic joint replacement of either hip or knee. Consenting patients will be randomized 2:1 to receive either ceftaroline or cefazolin/vancomycin. This study will be blinded by the use of placebo vancomycin infusions and placebo cephalosporin infusions. The primary end point will be the development of a surgical site infection within 30 days of surgery.
Key facts
- Study ID
- NCT02307006
- Run by
- University of Cincinnati
- People needed
- 500
- Starts
- 2015-01-01
- Expected to finish
- 2017-06-01
- Last updated by the study team
- 2015-12-02
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Informed Consent
- Age - 18 years and older
- Patients undergoing either hip or knee arthroplasty or cardiac surgery with sternotomy
- Body mass index (BMI) between 18 and 30 kg/m2 inclusive.
- Female subjects must have a negative serum pregnancy test and be using appropriate contraception.
You may not qualify if…
- Pregnancy
- Hypersensitivity or allergic reaction to any β-lactam antibiotic or vancomycin.
- Presence of cardiovascular shock,
- Receipt of chronic concomitant systemic corticosteroids, 40 mg of prednisone equivalent;
- Severe renal impairment (i.e. Creatinine clearance ≤ 30 mL/min);
- Significant hepatic impairment (i.e. known acute viral hepatitis, aspartate aminotransferase or alanine aminotransferase concentration 10-fold the upper limit of normal (ULN) or total bilirubin 3-fold the ULN or manifestations of end-stage liver disease, such as ascites or hepatic encephalopathy),
- Hematological impairment with current or anticipated neutropenia with less than 500 neutrophils/mm3 or thrombocytopenia with platelet count of 60 000 cells/mm3
- HIV infection which at the time of screening meets 2008 CDC criteria for AIDS.
- Patients undergoing revision surgery for infected prosthetic joint replacement.
- Body mass index (BMI) less than 18 or greater than 30 kg/m2.
- Concurrent antibiotics
Where it is running
- University of Cincinnati Medical Center — Cincinnati, Ohio, United States (enrolling)
- West Chester Hospital — West Chester, Ohio, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.